how to break a stall on semaglutide The GLP-1 Plateau: What It Is and Get Past It Semaglutide Plateau: Why Weight Loss

Bischoff-Ferrari HA, et al

In clinical trials, Wegovy demonstrated the ability to decrease body weight in individuals with body mass indices (BMIs) of 30 or higher by approximately 15% over 68 weeks

ONCOLOGY Vol 34 Issue 5 Volume 34 Issue 5 Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus Ipilimumab Experts discuss the case of a 56-year-old white man who presents with multiple immune-related adverse events A 56-year-old white man with a 74 pack-year smoking history presented with macroscopic hematuria and a significant weight loss of 45 pounds in 6 months

Yes, its been found to lower body mass in those with obesity, along with lowering weight, BMI, fat mass and weight circumference